The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
Brief Title: SCOT Registry: Small Cell Lung Cancer Treatment and Outcome
Official Title: SCOT Registry: Small Cell Lung Cancer Treatment and Outcome
Study ID: NCT00997061
Brief Summary: The registry is an international, multicenter, observational registry of newly diagnosed patients with SCLC. Data will be entered into an electronic CRF (eCRF) via Internet access. Treatment plan remains the responsibility of the patient's physician and data collected in this registry will reflect a "real world" approach of the diagnosis and treatment of patients with SCLC. Approximately 60 centres in 13 countries will take part in this registry. It is expected that about 500 patients will be recruited during a period of 6 to 9 months according to the feasibility.
Detailed Description:
Minimum Age: 18 Years
Eligible Ages: ADULT, OLDER_ADULT
Sex: ALL
Healthy Volunteers: No
GSK Investigational Site, Graz, , Austria
GSK Investigational Site, Innsbruck, , Austria
GSK Investigational Site, Salzburg, , Austria
GSK Investigational Site, Vienna, , Austria
GSK Investigational Site, Brno, , Czech Republic
GSK Investigational Site, Plzen, , Czech Republic
GSK Investigational Site, Tallinn, , Estonia
GSK Investigational Site, Besançon, , France
GSK Investigational Site, Caen, , France
GSK Investigational Site, Créteil, , France
GSK Investigational Site, Draguignan cedex, , France
GSK Investigational Site, Lorient cedex, , France
GSK Investigational Site, Paris, , France
GSK Investigational Site, Perpignan, , France
GSK Investigational Site, Pessac cedex, , France
GSK Investigational Site, Pierre Benite, , France
GSK Investigational Site, Saint-Priest en Jarez, , France
GSK Investigational Site, Strasbourg, , France
GSK Investigational Site, Muenchen, Bayern, Germany
GSK Investigational Site, Immenhausen, Hessen, Germany
GSK Investigational Site, Kassel, Hessen, Germany
GSK Investigational Site, Wiesbaden, Hessen, Germany
GSK Investigational Site, Leer, Niedersachsen, Germany
GSK Investigational Site, Bonn, Nordrhein-Westfalen, Germany
GSK Investigational Site, Hemer, Nordrhein-Westfalen, Germany
GSK Investigational Site, Koeln, Nordrhein-Westfalen, Germany
GSK Investigational Site, Velbert, Nordrhein-Westfalen, Germany
GSK Investigational Site, Athens, , Greece
GSK Investigational Site, Heraklion, Crete, , Greece
GSK Investigational Site, Thessaloniki, , Greece
GSK Investigational Site, Mátraháza, , Hungary
GSK Investigational Site, Székesfehérvár, , Hungary
GSK Investigational Site, Parma, Emilia-Romagna, Italy
GSK Investigational Site, Rozzano (MI), Lombardia, Italy
GSK Investigational Site, Orbassano (TO), Piemonte, Italy
GSK Investigational Site, Lecce, Puglia, Italy
GSK Investigational Site, Sassari, Sardegna, Italy
GSK Investigational Site, Seongnam-si, Gyeonggi-do, , Korea, Republic of
GSK Investigational Site, Seoul, , Korea, Republic of
GSK Investigational Site, Suwon, Gyeonggi-do, , Korea, Republic of
GSK Investigational Site, Kaunas, , Lithuania
GSK Investigational Site, Klaipeda, , Lithuania
GSK Investigational Site, Vilnius, , Lithuania
GSK Investigational Site, Vilnius, , Lithuania
GSK Investigational Site, Amsterdam, , Netherlands
GSK Investigational Site, Breda, , Netherlands
GSK Investigational Site, Eindhoven, , Netherlands
GSK Investigational Site, Groningen, , Netherlands
GSK Investigational Site, Glucholazy, , Poland
GSK Investigational Site, Gorzow Wielkopolski, , Poland
GSK Investigational Site, Krakow, , Poland
GSK Investigational Site, Lodz, , Poland
GSK Investigational Site, Lublin, , Poland
GSK Investigational Site, Warszawa, , Poland
GSK Investigational Site, Golnik, , Slovenia
GSK Investigational Site, Ljubljana, , Slovenia
GSK Investigational Site, Cordoba, , Spain
GSK Investigational Site, Madrid, , Spain
GSK Investigational Site, Madrid, , Spain
GSK Investigational Site, Palma de Mallorca, , Spain
GSK Investigational Site, Zaragoza, , Spain
Name: GSK Clinical Trials
Affiliation: GlaxoSmithKline
Role: STUDY_DIRECTOR